|
|
Article: UPDATE: Data Show Low Incidence Of Breakthrough Bleeding With ORTHO TRI-CYCLEN(R) LO in a Broad Range of Women.
- Article from:
- PR Newswire
- Article date:
- May 9, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SAN DIEGO, May 9 /PRNewswire/ -- Use of the widely used birth control pill, ORTHO TRI-CYCLEN(R) LO (norgestimate/ethinyl estradiol) Tablets, resulted in significantly lower rates of breakthrough bleeding and spotting in a broad range of women compared to another low-dose combination birth control pill, according to data presented today at the 55th Annual Clinical Meeting of The American College of Obstetricians and Gynecologists (ACOG).(1)
This analysis compared the breakthrough bleeding and spotting profiles of two low-dose birth control pills, containing either 25 mcg or 20 mcg of ethinyl estradiol and differing progestins, in women across a range of ages and ...